U.S. Infrastructure Stock News

Spectrum Brands Holdings, Inc. reported past third-quarter 2026 results showing sales of US$753.3 million and a net loss of US$26.8 million, alongside a US$104.0 million impairment of intangible assets, while maintaining guidance for flat to low single digit reported net sales growth for fiscal 2026. The combination of higher sales but weaker profitability and a sizeable write-down of intangible assets highlights pressure on the quality and sustainability of Spectrum Brands’ earnings...

The United States market remained flat over the last week, yet it has experienced a notable 20% rise over the past 12 months, with earnings forecast to grow by 17% annually. In this context, identifying stocks that are estimated to be below their intrinsic value can present opportunities for investors seeking potential growth in an evolving market landscape.

In the last week, the United States market has stayed flat, but over the past 12 months, it has risen by 20% with earnings forecasted to grow by 17% annually. In this context of growth and stability, companies with high insider ownership can be particularly appealing as they often reflect strong confidence from those who know the business best.

In the last week, the market has stayed flat, but it's up 20% over the past year, with earnings forecast to grow by 17% annually. In such a landscape, identifying stocks that balance potential growth with financial stability is crucial. Penny stocks may be an older term, yet they remain relevant for investors seeking opportunities in smaller or newer companies; those backed by strong fundamentals can offer both value and growth potential.

In the last week, the United States market has stayed flat, yet it is up 20% over the past year with earnings forecasted to grow by 17% annually. In this environment, selecting dividend stocks that offer consistent payouts and potential for growth can be a strategic move for investors seeking stability and income.

With the US national debt now above $40 trillion and interest costs eating a larger share of the federal budget, higher for longer rates are no longer just a talking point; they are a real pressure test for portfolios. Some stocks may quietly benefit from this reset in borrowing costs, while others could struggle. This article picks out 3 stocks exposed to this macro shock and explains why each one might deserve a closer look right now. The 3 stocks in focus below are just a sample from a...

Alphabet (NasdaqGS:GOOGL) expanded its AI chip collaboration with Marvell Technology, including an option arrangement disclosed at up to US$12.2b in Marvell shares. The value of the option is tied to the volume of AI chip business Google directs to Marvell across inference, networking, storage, memory and near-memory computing. The partnership is aimed at building custom AI hardware that can sit alongside Alphabet's existing solutions and provide alternatives to other large chip...

Mosaic (MOS) has just closed a new US$2.0b senior notes offering and outlined plans to use most of the proceeds to buy back shorter term bonds, refinance debt and fund general corporate purposes. See our latest analysis for Mosaic. Mosaic shares have reacted positively to the refinancing news with a 1-day share price return of 5.16%, although year to date the share price return is down 11.15% and the 1-year total shareholder return has declined 29.09%, pointing to fading longer term...

Alkermes (ALKS) drew investor attention after amending its February 2026 credit agreement, reducing interest rate spreads on its senior secured term loan A and term loan B facilities maturing in 2031. See our latest analysis for Alkermes. Alkermes shares trade at US$50.18 after a 1-day share price return of 1.41%, and the stock shows strong momentum with a 90-day share price return of 35.81% and a 1-year total shareholder return of 73.21%, alongside an 82.72% total shareholder return over...

Regeneron Pharmaceuticals (NasdaqGS: REGN) received FDA approval for Pasatru (garetosmab-grts) as the first treatment for adults with fibrodysplasia ossificans progressiva to reduce new heterotopic ossification lesions and flare-ups. The approval is based on Phase 3 trial results and introduces a new therapeutic franchise for Regeneron beyond its existing portfolio. Pasatru targets a rare and severely disabling condition, expanding Regeneron's reach in rare disease treatments. This kind of...

In recent weeks, AbbVie has highlighted the pending review of a subcutaneous induction option for SKYRIZI in Crohn’s disease, continued portfolio expansion through deals such as its roughly US$10.90 billion Apogee Therapeutics acquisition, and the ongoing recognition of its long-running immunology scholarship program. Together, these developments underscore how heavily AbbVie’s outlook is tied to SKYRIZI’s future use, while it simultaneously invests in new therapies and reinforces its image...

Glaukos stock has delivered very strong gains over the last five years, yet the current valuation checks and market multiples suggest the shares now lean expensive rather than clearly cheap. Glaukos has returned 260.2% over the past 5 years, which puts extra focus on whether the current price still leaves enough room for a reasonable long term return. Expectations for continued growth in ophthalmology treatments can support today’s price, while any setback in execution or slower revenue...

SFL Corporation Ltd. recently moved into focus ahead of its now‑completed Q2 FY26 earnings, as investors assessed how its contract-heavy fleet supports dependable cash distributions amid a higher-cost capital backdrop. The company’s earlier decision to lift its quarterly dividend after a stable Q1, citing confidence in contracted cash flows, has sharpened attention on whether upcoming results will confirm the strength and quality of its recurring earnings base. We’ll now examine how this...

Global inflation remains a concern and recent US Federal Reserve minutes flagged the risk that price pressures could re accelerate. In that kind of rate sensitive setting, companies that can grow earnings from a solid financial base often attract more attention as investors look for growth that does not rely on cheap money. This article highlights three stocks from the Healthy high growth potential screener that fit that profile. The stocks below are just a starting sample from this Healthy...

Upcoming Q2 2026 earnings call puts Ollie's Bargain Outlet Holdings (OLLI) in focus Ollie's Bargain Outlet Holdings (OLLI) is drawing attention ahead of its upcoming second quarter fiscal 2026 earnings release on Wednesday, September 2, 2026, before the market opens. Management will host a conference call at 8:30 a.m. Eastern Time to discuss the results and answer investor questions, with a live webcast and replay available through the company’s Investor Relations website. See our latest...

T. Rowe Price Group previously announced that its Board of Directors declared a quarterly dividend of US$1.30 per share, payable on September 29, 2026, to stockholders of record as of September 15, 2026. Despite this cash return to shareholders, analysts remain cautious as mixed Q2 2026 results, weak long-term growth, and continued net client outflows weigh on their views. With analysts still concerned about ongoing net client outflows, we'll now examine how this latest news shapes T. Rowe...

Cirrus Logic (CRUS) heads into its August 11 appearance at the KeyBanc Technology Leadership Forum with fresh attention on its custom smartphone revenue, along with renewed debate about whether its current share price reflects underlying cash flows. See our latest analysis for Cirrus Logic. Recent trading reflects mixed sentiment. Cirrus Logic’s share price is up 1.02% over the last day but down 13.69% over 30 days and 29.14% over 90 days. Its 3-year total shareholder return of 47.72% points...

Neogen Corporation (NasdaqGS: NEOG) announced the resignation of board member Thierry Bernard from its board of directors. The company disclosed the board change as a governance update for shareholders and other stakeholders. Bernard's departure adjusts the composition of Neogen's board, which is responsible for oversight of management and long term direction. Board changes at Neogen sit within a wider pattern of investors watching for resilient leadership and steadier business models,...

TD SYNNEX stock has delivered very strong gains over the past few years, while both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples currently point to the shares trading below what these models suggest. Over the past 3 years, TD SYNNEX has returned 164.3%, which puts added focus on whether the current share price still leaves a valuation cushion. Expectations for continued cash flow generation can support the current valuation. However, any pressure on...

Delek Logistics Partners, LP recently completed a US$200 million follow-on equity offering of 4,000,000 common units at US$50 per unit, with Huntington Securities, Inc. and Citizens JMP Securities, LLC added as co-lead underwriters. This capital raise meaningfully increases the partnership’s equity base, which could influence future funding decisions, distribution policy, and balance sheet flexibility. Next, we’ll examine how this US$200 million equity issuance may reshape Delek Logistics...

GrowthLoop launched a new end-to-end commerce media network solution that integrates with The Trade Desk (NasdaqGM:TTD) as a key adtech partner. The platform is designed for retail and commerce media teams to run campaigns with a more unified advertising technology stack. GrowthLoop's use of The Trade Desk aims to support more seamless media activation and workflow management across commerce media networks. This kind of collaboration in commerce media and AI driven adtech is part of a wider...

With no specific news catalyst flagged, interest in Andersons (ANDE) today centers on how its recent price moves compare with its underlying agribusiness and renewables footprint across the United States, Canada, Mexico and other international markets. See our latest analysis for Andersons. Andersons’ share price has pulled back over the past month with a 30 day share price return of a 12.7% decline and a 90 day share price return of a 3.6% decline. However, the year to date share price...

SoftBank Group has disclosed a concentrated position in Intel (NasdaqGS: INTC), with the stock now representing 67% of its U.S. equity portfolio. The commitment reflects a US$2b investment in Intel shares, according to SoftBank's latest portfolio disclosure. The scale of this single stock exposure is unusual for an investor of SoftBank's size and may influence how other institutions view Intel. For readers tracking how large investors are positioning around AI infrastructure, the wider...

Kimbell Royalty Partners (KRP) just paired a higher second quarter cash distribution with stronger reported revenue and net income, while also pointing to a steady pipeline of acquisition opportunities. See our latest analysis for Kimbell Royalty Partners. At a share price of $15.04, Kimbell Royalty Partners has paired a modest 1-day share price gain of 0.87% with a stronger year to date share price return of 25.02%. The 5-year total shareholder return of 146.78% points to longer term...